David M Goldstein - Net Worth and Insider Trading
David M Goldstein Net Worth
The estimated net worth of David M Goldstein is at least $3 Million dollars as of 2024-11-05. David M Goldstein is the Chief Scientific Officer of Principia Biopharma Inc and owns about 31,739 shares of Principia Biopharma Inc (PRNB) stock worth over $3 Million. Details can be seen in David M Goldstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David M Goldstein has not made any transactions after 2020-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David M Goldstein
David M Goldstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David M Goldstein owns 1 companies in total, including Principia Biopharma Inc (PRNB) .
Click here to see the complete history of David M Goldstein’s form 4 insider trades.
Insider Ownership Summary of David M Goldstein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRNB | Principia Biopharma Inc | 2020-09-28 | Chief Scientific Officer |
David M Goldstein Latest Holdings Summary
David M Goldstein currently owns a total of 1 stock. David M Goldstein owns 31,739 shares of Principia Biopharma Inc (PRNB) as of August 10, 2020, with a value of $3 Million.
Latest Holdings of David M Goldstein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRNB | Principia Biopharma Inc | 2020-08-10 | 31,739 | 100.05 | 3,175,487 |
Holding Weightings of David M Goldstein
David M Goldstein Form 4 Trading Tracker
According to the SEC Form 4 filings, David M Goldstein has made a total of 4 transactions in Principia Biopharma Inc (PRNB) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Principia Biopharma Inc is the sale of 6,000 shares on August 10, 2020, which brought David M Goldstein around $531,660.
Insider Trading History of David M Goldstein
- 1
David M Goldstein Trading Performance
David M Goldstein Ownership Network
Ownership Network List of David M Goldstein
Ownership Network Relation of David M Goldstein
David M Goldstein Owned Company Details
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
David M Goldstein is the Chief Scientific Officer of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Business Officer Roy C. Hardiman .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
David M Goldstein Mailing Address
Above is the net worth, insider trading, and ownership report for David M Goldstein. You might contact David M Goldstein via mailing address: C/o Principia Biopharma Inc. 400 East Jamie Court, Suite 302 South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
